14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:NYMX
Delisted

Nymox Pharmaceutical Corporation Stock Price (Quote)

NASDAQ Stock Exchange > Healthcare > Biotechnology
Open Broker Account
$0.200
+0 (+0%)
At Close: Nov 10, 2023
Forecast Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $0.200 $0.200 Friday, 10th Nov 2023 NYMX stock ended at $0.200. During the day the stock fluctuated 0% from a day low at $0.200 to a day high of $0.200.
90 days $0.200 $0.200
52 weeks $0.170 $1.10

Historical Nymox Pharmaceutical Corporation prices

Date Open High Low Close Volume
Nov 10, 2023 $0.200 $0.200 $0.200 $0.200 0
Nov 09, 2023 $0.200 $0.200 $0.200 $0.200 0
Nov 08, 2023 $0.200 $0.200 $0.200 $0.200 0
Nov 07, 2023 $0.200 $0.200 $0.200 $0.200 0
Nov 06, 2023 $0.200 $0.200 $0.200 $0.200 0
Nov 03, 2023 $0.200 $0.200 $0.200 $0.200 0
Nov 02, 2023 $0.200 $0.200 $0.200 $0.200 0
Nov 01, 2023 $0.200 $0.200 $0.200 $0.200 0
Oct 31, 2023 $0.200 $0.200 $0.200 $0.200 0
Oct 30, 2023 $0.200 $0.200 $0.200 $0.200 0
Oct 27, 2023 $0.200 $0.200 $0.200 $0.200 0
Oct 26, 2023 $0.200 $0.200 $0.200 $0.200 0
Oct 25, 2023 $0.200 $0.200 $0.200 $0.200 0
Oct 24, 2023 $0.200 $0.200 $0.200 $0.200 0
Oct 23, 2023 $0.200 $0.200 $0.200 $0.200 0
Oct 20, 2023 $0.200 $0.200 $0.200 $0.200 0
Oct 19, 2023 $0.200 $0.200 $0.200 $0.200 0
Oct 18, 2023 $0.200 $0.200 $0.200 $0.200 0
Oct 17, 2023 $0.200 $0.200 $0.200 $0.200 0
Oct 16, 2023 $0.200 $0.200 $0.200 $0.200 0
Oct 13, 2023 $0.200 $0.200 $0.200 $0.200 0
Oct 12, 2023 $0.200 $0.200 $0.200 $0.200 0
Oct 11, 2023 $0.200 $0.200 $0.200 $0.200 0
Oct 10, 2023 $0.200 $0.200 $0.200 $0.200 0
Oct 09, 2023 $0.200 $0.200 $0.200 $0.200 0
Click to get the best stock tips daily for free!

About Nymox Pharmaceutical Corporation

Nymox Pharmaceutical Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population in Canada, the United States, Europe, and internationally. Its lead drug candidate is Fexapotide Triflutate (NX-1207), which has completed Phase III clinical trials for the treatment of benign prostatic hyperplasia, and Phase II clinical trials for low grade localized prostate cancer, as well as is in preclinica... NYMX Profile

Golden Star

Ticker Date Change Price
CVBF May 01 2.75% $16.75
FTSL May 01 0.282% $46.03
EQC Apr 30 0.694% $18.72
HRB Apr 30 0.635% $47.23
BSCQ Apr 30 0.576% $19.09
BSJP Apr 29 0.306% $22.91
LYG Apr 29 1.56% $2.56
ORA Apr 29 4.68% $64.48
DHT Apr 24 3.10% $11.28
LPLA Apr 19 3.12% $262.59
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT